#hydroxycholoroquine

Social media: *deletes and blocks all posts mentioning them in a positive light*

Media: ONE OF THOSE DOCTORS HAS RELIGIOUS VIEWS COMMON TO THE REGION OF AFRICA SHE’S FROM!!!!

Squarespace: *deletes the website the doctors made to share info*

CDC: *buys a similar domain name to the one the doctors had and makes it redirect to the CDC website*

This doctor is trying to treat COVID-19 patients with hydroxychloroquine and pharmacies are refusing to fill prescriptions for her unless she gives them confidential patient information (in violation of HIPAA).They claim “the law has changed”. She’s not buying it. 

Pharmacies are now FLAT-OUT REFUSING to fill any prescriptions for her. 

Meanwhile she has patients with severe pneumonia from COVID-19 who need treatment NOW. 

This doctor says that every single patient that she has treated with hydroxychloroquine has shown improvement within hours and either has fully recovered or is on the way to full recovery. 

Y’all, this is the government holding life-saving medication hostage in exchange for patients’ private medical information. 

And this is TEXAS. 

Hydroxychloroquine अमेरिका में उच्च रूप से राजनीतिक हो गया है, लेकिन भारत इसका व्यापक रूप से उपयोग करता है: व्हाइट हाउस आधिकारिक

दवा हाइड्रोक्सीक्लोरोक्वीन की फाइल फोटो। (रायटर)

उन्होंने कहा कि यह एक खतरनाक दवा है, यह केवल मूर्खतापूर्ण है, लेकिन अगर आप अमेरिकी लोगों से मीडिया के कवरेज के आधार पर पूछते हैं, तो यह अभी खेलने की स्थिति की तरह है, उन्होंने कहा।

PTI वाशिंगटन

आखरी अपडेट: 8 जुलाई, 2020, सुबह 9:31 बजे IST

कोरोनोवायरस रोगियों के इलाज के लिए हाइड्रोक्सीक्लोरोक्वीन का उपयोग अमेरिका में अत्यधिक राजनीतिकरण हो गया…

HYDROXYCHLOROQUINE     EP IMPURITY A

CAT No     : ALL-HDC-A

Chemical     Name : 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethyloxidoamino]-ethanol

Molecular     Formula : C18H26ClN3O2

Molecular     Weight : 351.87

CAS     Number : 1449223-88-4

Solubility     : MEOH

Storage     : 2-8

Keywords     : HYDROXYCHLOROQUINE EP IMPURITY A, HYDROXYCHLOROQUINE SULFATE,     HYDROXYCHLOROQUINE EP IMPURITY A, HYDROXYCHLOROQUINE RELATED COMPOUND A,     UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD, HYDROXYCHLOROQUINE     N-OXIDE

Purity     by HPLC : 98%

Documents - COA, HNMR, 13CNMR, MASS, HPLC (by pharmacopoeia method with RT RRT results), IR and TGA will be provided with the purchase of HYDROXYCHLOROQUINE EP IMPURITY A is manufactured by ALLMPUS LABORATRIES PVT. Ltd. And are delivered and packaged according to regulations and Non-Infectious Biology Material and is purely for research purpose only not for human consumption. All documents as per pharmacopeia specification including MSDS/SDS, SER REPORT, COA, HPLC, MASS, 13CNMR, 1HNMR and TGA potency (Upto 800 deg c) and are acceptable to all various regulatory authorities such as ICH, USFDA, Canadian Drug and Health Agency & also used for ANDA filing /DMF filing and genotoxic study The materials are used purely for Testing, R & D and analytical Research Purposes and the Material is not from livestock or avian species and has not been exposed to livestock or avian disease agents. The Material is not immunogen and does not come from a facility where work with any viruses is done. The Material is not recombinant and do not contain any genes associated with livestock or poultry.

Hydroxycholoroquine trial suspended; WHO

The World Health Organisation (WHO) has temporarily suspended the trial of hydroxycholoroquine, a drug that was recommended against Coronavirus. The drug was suspended following safety concerns.

WHO Director-General Tedros Adhanom Ghebreyesus told the media that the Executive Group has imposed a temporary pause of the trial of hydroxychloroquine within Solidarity Trial arm. However, he said that…

Hydroxycholoroquine trial suspended; WHO

The World Health Organisation (WHO) has temporarily suspended the trial of hydroxycholoroquine, a drug that was recommended against Coronavirus. The drug was suspended following safety concerns.

WHO Director-General Tedros Adhanom Ghebreyesus told the media that the Executive Group has imposed a temporary pause of the trial of hydroxychloroquine within Solidarity Trial arm. However, he said that…

Express News Service

BENGALURU: Following a global demand for Hydroxycholoroquine (HCQ) as a possible prophylactic for COVID-19 healthcare workers and close contacts of the positive patients, the Central government has asked private pharmaceutical companies, which manufacture HCQ, to step up production. India is the leading manufacturer of HCQ in the world and IPCA Laboratories and Zydus Cadila…